Populations Publication Details



Malaysia Mandailing

Polymorphic Region:

1A*11:01 A*24:02 B*15:13 B*18:01 untyped untyped DRB1*04:05 DRB1*15:02
2A*02:01 A*24:02 B*15:02 B*18:01 untyped untyped DRB1*12:02 DRB1*15:01
3A*02:01 A*24:07 B*15:02 B*15:02 untyped untyped DRB1*12:02 DRB1*16:02
4A*24:02 A*24:02 B*35:03 B*51:02 untyped untyped DRB1*13:01 DRB1*14:04
5A*24:02 A*24:02 B*15:13 B*58:01 untyped untyped DRB1*03:01 DRB1*12:02
6A*02:01 A*33:03 B*15:02 B*15:13 untyped untyped DRB1*11:04 DRB1*14:28
7A*02:01 A*24:02 B*51:02 B*51:02 untyped untyped DRB1*12:02 DRB1*15:02
8A*11:01 A*24:07 B*35:05 B*44:03 untyped untyped DRB1*07:01 DRB1*15:02
9A*02:03 A*24:07 B*15:13 B*35:05 untyped untyped DRB1*15:02 DRB1*15:02
10A*02:01 A*02:03 B*15:13 B*15:13 untyped untyped DRB1*11:06 DRB1*15:02
11A*24:02 A*24:07 B*18:01 B*27:06 untyped untyped DRB1*12:01 DRB1*15:04
12A*11:01 A*11:01 B*15:13 B*51:01 untyped untyped DRB1*12:02 DRB1*15:04
13A*01:01 A*24:02 B*15:13 B*37:01 untyped untyped DRB1*03:01 DRB1*12:02
14A*02:01 A*02:01 B*15:02 B*15:13 untyped untyped DRB1*12:02 DRB1*12:02
15A*02:01 A*24:02 B*15:02 B*15:13 untyped untyped DRB1*12:02 DRB1*15:02
16A*02:01 A*02:03 B*15:13 B*18:01 untyped untyped DRB1*11:04 DRB1*14:28
17A*02:01 A*24:07 B*18:01 B*35:05 untyped untyped DRB1*12:02 DRB1*15:02
18A*01:01 A*02:01 B*15:02 B*57:01 untyped untyped DRB1*07:01 DRB1*12:02
19A*02:03 A*02:06 B*15:13 B*15:13 untyped untyped DRB1*12:02 DRB1*15:02
20A*02:03 A*03:02 B*07:05 B*15:13 untyped untyped DRB1*10:01 DRB1*15:02
21A*11:01 A*33:03 B*39:01 B*52:12 untyped untyped DRB1*14:04 DRB1*15:02
22A*02:01 A*11:01 B*15:02 B*38:02 untyped untyped DRB1*12:02 DRB1*15:03
23A*02:01 A*24:07 B*51:02 B*51:02 untyped untyped DRB1*09:01 DRB1*12:02
24A*02:01 A*24:10 B*15:27 B*38:02 untyped untyped DRB1*04:06 DRB1*15:02
25A*02:01 A*31:01 B*07:02 B*51:02 untyped untyped DRB1*12:02 DRB1*15:38
26A*24:02 A*24:07 B*15:02 B*27:06 untyped untyped DRB1*12:02 DRB1*12:02
27A*02:01 A*11:01 B*08:01 B*15:13 untyped untyped DRB1*03:20 DRB1*11:04

Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations.
Gonzalez-Galarza FF, Takeshita LY, Santos EJ, Kempson F, Maia MH, Silva AL, Silva AL, Ghattaoraya GS, Alfirevic A, Jones AR and Middleton D Nucleic Acid Research 2015, 39, 28, D784-8.
Liverpool, U.K.


Valid XHTML 1.0 Transitional